MIRA INFORM REPORT

 

 

Report Date :

24.09.2014

 

IDENTIFICATION DETAILS

 

Name :

CALYX CHEMICALS AND PHARMACEUTICALS LIMITED

 

 

Formerly Known As :

CALYX CHEMICALS AND PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

Unit No.110, Marwah’s Complex, Krishanlal Marwah Estate, Off. Saki Vihar Road, Andheri (East), Mumbai – 400072, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

14.01.1986

 

 

Com. Reg. No.:

11-038618

 

 

Capital Investment / Paid-up Capital :

Rs. 160.489 Millions

 

 

CIN No.:

[Company Identification No.]

U24220MH1986PLC038618

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMC07976D/ MUMC09940A

 

 

PAN No.:

[Permanent Account No.]

AABCC1457B

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Subject is engaged in manufacturing and dealing in Active Pharmaceutical Ingredients (APIs), Intermediates and Contract research and manufacturing services.

 

 

No. of Employees :

500 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (50)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 7200000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Exist

 

 

Comments :

Subject is an established company having a satisfactory track record.

 

As per Registrar of Companies the date of Balance Sheet i.e. financials filed is shown as 31st March 2013 but the documents related to the financials for the year 2013 are not available from any sources.

 

As per available financials 2012, financial position of the company seems to be decent.

 

However, trade relations are fair. Business is active. Payment terms are usually correct.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

Verdict Implications : Apex court order may alter coal import dynamics. Traders go slow on talks over coal supply contracts, uncertainty over cancellation of blocks weigh on stocks.

 

Recent arrest of the Chennai head of the Registrar of Companies, the ministry of corporate affairs arm that ensures that companies file all the information required by the Companies Act is the latest manifestation of a messy fight between a father and his adopted son for the control of Rs 40000 mn business empire. The Central Bureau of Investigation arrested Manumeethi Cholan after he accepted Rs 10 lakhs as bribe from M A M Ramaswamy, a CBI official said.

 

Central Bureau of Investigation books Electrotherm for cheating Central Bank of Rs 4360 mn.

 

Infosys maintains revenue guidance. COO Rao says attrition still an area of concern and it would take a few more quarters to bring down levels to 13-15 %.

 

DHL  to invest Euro 100 mn in India over next 2 years. The firm has chosen India to pilot its e-commerce business model for the Asia-Pacific region.

 

Blackstone may buy stake in BlueRidge SEZ in line with the fund’s real estate strategy in India.

 

Kingfisher Airlines Ltd grounded in October 2012 under the weight of heavy debt and accumulated losses, recently approached the Delhi high court for relief in two separate cases. The airline challenged a notice by Punjab & National Bank alleging that It had wilfully defaulted on Rs 7700 mn of loans and sought more time to comply with the requirements under the listing agreements with the Stock Exchanges.

 

OnMobile likely to sack another 300 employees. The lay-offs follow a spate of senior-level exits over the past two years, starting with of its founder. The overall lay-offs could number around 600 and are driven by the need to cut costs, says a former employee.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Issues Rating = BBB- (Suspended)

Rating Explanation

Moderate degree of safety and moderate credit risk.

Date

11.02.2014

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION PARTED BY

 

Name :

Ms. Swati

Designation :

Accounts Department

Contact No.:

91-22-28571191

Date :

24.09.2014

 

 

LOCATIONS

 

Registered Office :

Unit No.110, Marwah’s Complex, Krishanlal Marwah Estate, Off. Saki Vihar Road, Andheri (East), Mumbai – 400072, Maharashtra, India

Tel. No.:

91-22-28571191/ 82/ 28575037

Fax No.:

91-22-66466401

E-Mail :

dipali_dorugade@calyxindia.com

calyx@calyxindia.com

devanand_mojidra@calyxindia.com

pooja_gaonkar@calyxindia.com

Website :

www.clydxindia.com

www.calyx-pharma.com

Area :

3000 Sq. ft.

 

 

Corporate Office :

A-37/38, MIDC, Phase 1, Golavli, Kalyan Shil Road, Dombivali (East), Near Vicconaka, Thane – 421203, Maharashtra, India

Tel. No.:

91-251-2438310/ 6698300

Fax No.:

91-251-2438726

E-Mail :

sales@calyxindia.com

crams@calyxindia.com

 

 

Factory 1 :

N 91/102, Tarapur Industrial Area, Boisar, District Thane, Maharashtra, India

 

 

Factory 2 :

W 212/213, MIDC, Phase II, Sonarpada, Dombivali (East), District Thane, Maharashtra, India

 

 

DIRECTORS

 

As on: 27.09.2013

 

Name :

Mr. Smitesh Chandravadan Shah

Designation :

Managing Director

Address :

B-403, Eden – III, Hiranadani Grdens, Powai, Mumbai – 400 076, Maharashtra, India

Date of Birth/Age :

28.04.1959

Qualification :

B.com

Date of Appointment :

01.04.2013

PAN No.:

AMUPS4238C

DIN No.:

00019720

 

 

Name :

Mr. Bharat Sukhlal Mehta

Designation :

Director

Address :

21, Nibbana Pali Hill, Bandra (West), Mumbai – 400 050, Maharashtra, India

Date of Birth/Age :

05.01.1938

Qualification :

MBA

Date of Appointment :

31.03.2010

PAN No.:

AAAPM7952K

DIN No.:

00038165

 

 

Name :

Mr. Rajat Indulal Doshi

Designation :

Director

Address :

1 E, Dil Pazir, Bhulabhai Desai Road, Cumballa, Gamdevi, Mumbai – 400 026, Maharashtra, India

Date of Birth/Age :

13.10.1958

Qualification :

B.com

Date of Appointment :

30.09.2009

PAN No.:

AABPD9790M

DIN No.:

02423171

 

 

Name :

Mr. Abhay Prafulchandra Desai

Designation :

Director

Address :

Flat No 502, Glen Classic Apts, Hiranandani Gardens, Powai Mumbai – 400076, Maharashtra, India 

Date of Birth/Age :

27.06.1962

Date of Appointment :

23.03.2010

DIN No.:

03016913

 

 

KEY EXECUTIVES

 

Name :

Ms. Swati

Designation :

Account Department

 

 

Name :

Mr. Devanand P. Mojidra

Designation :

Company Secretary

Address :

A/504, Kamala Ashish Building, 3 CHS Limited, Mahavir Nagar, Dahanukar Wadi, Kandivali (West), Mumbai – 400 067, Maharashtra, India 

Date of Birth/Age :

07.02.1973

Date of Appointment :

11.05.2012

PAN No.:

AHRPM7047F

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 27.09.2013

 

SHAREHOLDING LIST ATTACHED

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 27.09.2013

 

Category

 

Percentage

 

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

10.20

Bodies corporate

 

2.97

Directors or relatives of directors

 

75.56

Other

 

11.27

 

 

 

Total

 

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in manufacturing and dealing in Active Pharmaceutical Ingredients (APIs), Intermediates and Contract research and manufacturing services.

 

 

Products :

Item Code No. (ITC Code)

Product Description

Pyrazina

29242960

Erythrom

29415000

Erystear

29415000

Artemether

29420090

 

 

Exports :

 

Products :

Finished Goods

Countries :

·         USA

·         China

·         Dubai

 

 

Imports :

 

Products :

Raw Material

Countries :

China

 

 

Terms :

 

Selling :

Cash / Credit / LC

 

 

Purchasing :

Cash / Credit / LC

 

PRODUCTION STATUS [AS ON 31.03.2011]

 

Particulars

Unit

Installed Capacity

Actual Production*

Active Pharmaceutical Ingredients, Intermediate and Chemicals

MT

127463

1743

 

NOTE:

 

·         The Installed capacity has been certified by the management.

·         Includes outsourced, contract manufactured and bought out goods

 

GENERAL INFORMATION

 

Suppliers :

C J Shah and Company

 

 

Customers :

Sandos Limited

 

 

No. of Employees :

500 (Approximately)

 

 

Bankers :

·         Jammu and Kashmir bank limited, India

·         UCO Bank, MCU Andheri (West), Marol Maroshi Road, Next to Marol Fire Bridge, Andheri (East), Mumbai – 400059, Maharashtra, India

·         State Bank of Bikaner and Jaipur, Commercial Network Branch, 239, P Demello Road, Opposite GPO, Fort, Mumbai – 400001, Maharashtra, India

·         State Bank of Hyderabad, New India Assurance Company Building Ground Floor, 87, Mahatma Gandhi Road, Mumbai – 400001, Maharashtra, India

·         Export-Import Bank of India, Centre One Building, Floor 21, World Trade Centre Complex, Cuffe Parade, Mumbai – 400005, Maharashtra, India

·         State Bank of India, Backbay Reclamation Branch, Raheja Chambers, Nariman Point, Mumbai – 400021, Maharashtra, India

·         Corporation Bank, Large Corporate Branch, Eagles Flight, Suren Road, Andheri (East), Mumbai - 400093, Maharashtra, India

·         Punjab National Bank, Brady House, V.N. Road, Fort, Mumbai - 400023, Maharashtra, India

·         Bank of India, Andheri MID Corporate Branch, M.D.I Building, First Floor, 28 S.V Road, Andheri (West), Mumbai - 400058, Maharashtra, India

·         State Bank of India

·         State Bank of Mysore

·         IDBI Bank Limited

·         Oriental Bank of Commerce

·         State Bank of Patiala

·         Kotak Mahindra Bank Limited

·         Standard Chartered Bank

·         Indian Overseas Bank

·         State Bank of Mysore

·         Bank of Bahrain and Kuwait

·         Allahabad Bank

·         Canara Bank

·         ING Vysya Bank

·         State Bank of Mauritius

 

 

Facilities :

Fund and Non-Fund Rs.3000.000 Million (From State Bank of India)

(Rs. In Millions)

SECURED LOANS

31.03.2012

(Rs. in Millions)

31.03.2011

(Rs. in Millions)

LONG TERM BORROWINGS

 

 

Rupee term loans from banks

(First Pari Passu Charge by way of hypothecation over entire movable Fixed Assets and mortgage over the entire immovable properties of the Company present and future. First Pari Passu charge on all fixed assets and subservient charge on current assets of the company.First Pari Passu charge on all fixed assets of the company along with existing and proposed other lenders)

1016.326

1035.516

 

 

 

SHORT TERM BORROWINGS

 

 

Working capital loans from banks

(Primary Security: - First pari-passu charge on entire current assets of the company. Collateral Security:- Second

pari-passu charge on entire fixed assets of the company)

1577.492

924.364

Total

2593.818

1959.880

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Jatin V. Shah

Chartered Accountant

Address :

261/263, D N Road, 4th Floor, Mumbai – 400 001, Maharashtra, India

Tel. No.:

91-22-32948140

Fax No.:

91-22-22610775

PAN No.:

AVVPS9231R

 

 

Subsidiaries :

Singind Life Sciences Pte. Limited, Singapore

 

 

Entities over which Key Management Personnel exercise significant influence/ Others:

·         Top Brass Gifts Private Limited

CIN No.: U18101MH1993PTC072347

·         Sukhlal Mansukhlal Herbals (Formerly Known as Sum Electronics)

·         Sum Electronics

·         Calyx Employees Welfare Trust

 

 

Sister Concern :

·         Calyx Chemical LLC, Dubai

·         Calyx International USA

 

 

CAPITAL STRUCTURE

 

As on 27.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

30000000

Equity Shares

Rs.10/- each

Rs.300.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

16413473

Equity Shares

Rs.10/- each

Rs.164.135 Millions

 

 

 

 

 

 

As on 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

30000000

Equity Shares

Rs.10/- each

Rs.300.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

16048890

Equity Shares

Rs.10/- each

Rs.160.489 Millions

 

 

 

 

 

 

 


 

FINANCIAL DATA

[All figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1) Shareholders' Funds

 

 

 

(a) Share Capital

 

160.489

159.332

(b) Reserves & Surplus

 

1597.865

1187.591

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

57.704

0.000

Total Shareholders’ Funds (1) + (2)

 

1816.058

1346.923

 

 

 

 

(3) Non-current liabilities

 

 

 

(a) Long-term borrowings

 

1066.429

1175.607

(b) Deferred tax liabilities (Net)

 

207.870

166.238

(c) Other long term liabilities

 

400.844

366.641

(d) Long-term provisions

 

10.153

0.000

Total Non-current Liabilities (3)

 

1685.296

1708.486

 

 

 

 

(4) Current liabilities

 

 

 

(a) Short term borrowings

 

1577.492

1024.364

(b) Trade payables

 

1761.960

646.052

(c) Other current liabilities

 

365.940

373.154

(d) Short-term provisions

 

67.992

26.074

Total Current Liabilities (4)

 

3773.384

2069.644

 

 

 

 

TOTAL

 

7274.738

5125.053

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

1184.938

973.880

(ii) Intangible Assets

 

481.306

486.320

(iii) Capital work-in-progress

 

88.360

88.762

(iv) Intangible assets under development

 

442.941

345.699

(b) Non-current Investments

 

2.981

2.713

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

29.850

27.883

(e) Other Non-current assets

 

18.669

34.523

Total Non-Current Assets

 

2249.045

1959.780

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

5.159

4.889

(b) Inventories

 

2629.276

1868.138

(c) Trade receivables

 

1796.906

920.727

(d) Cash and cash equivalents

 

464.735

188.012

(e) Short-term loans and advances

 

129.617

183.507

(f) Other current assets

 

0.000

0.000

Total Current Assets

 

5025.693

3165.273

 

 

 

 

TOTAL

 

7274.738

5125.053

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

135.360

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

780.482

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

915.842

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

1579.865

2] Unsecured Loans

 

 

295.949

TOTAL BORROWING

 

 

1875.814

DEFERRED TAX LIABILITIES

 

 

156.246

 

 

 

 

TOTAL

 

 

2947.902

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

1453.601

Capital work-in-progress

 

 

0.000

 

 

 

 

INVESTMENT

 

 

1.020

DEFERRED TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
 
1223.411

 

Sundry Debtors

 
 
729.227

 

Cash & Bank Balances

 
 
242.460

 

Other Current Assets

 
 
0.000

 

Loans & Advances

 
 
286.456

Total Current Assets

 
 
2481.554

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Sundry Creditors

 
 
913.307

 

Other Current Liabilities

 
 
43.003

 

Provisions

 
 
50.057

Total Current Liabilities

 
 
1006.367

Net Current Assets

 
 
1475.187

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

18.094

 

 

 

 

TOTAL

 

 

2947.902

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Revenue from operations

5891.861

4171.774

3218.025

 

 

Other Income

30.139

14.766

48.662

 

 

TOTAL                                     (A)

5922.000

4186.540

3266.687

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of materials consumed

4528.358

3038.899

 

 

 

Purchase of Stock-in-trade

292.979

0.000

 

 

 

Changes in inventories of finished goods, work-in-progress and stock-in-trade

(685.316)

(114.644)

 

 

 

Employee benefits expenses

160.826

125.302

 

 

 

Manufacturing Expenses

154.482

125.278

 

 

 

Administration Expenses

254.964

175.704

 

 

 

Selling and Distribution Expenses

32.577

41.297

 

 

 

Research and Development Expenses

19.811

22.176

 

 

 

TOTAL                                     (B)

4758.681

3414.012

2681.255

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

1163.319

772.528

585.432

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

455.870

286.637

232.453

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

707.449

485.891

352.979

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

129.430

97.704

77.371

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

578.019

388.187

275.608

 

 

 

 

 

Less

TAX                                                                  (H)

161.836

91.461

67.238

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

416.183

296.726

208.370

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

837.922

598.665

422.057

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Interim Equity Dividend Paid

15.934

0.000

31.762

 

 

Tax on Interim Dividend

2.585

0.000

 

 

 

Proposed Final Equity Dividend

12.037

23.900

 

 

 

Tax on Dividend

1.953

3.969

 

 

 

Transfer to General Reserves

41.600

29.600

 

 

BALANCE CARRIED TO THE B/S

1179.996

837.922

598.665

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

FOB Value of Exports

1486.344

817.867

389.208

 

TOTAL EARNINGS

1486.344

817.867

389.208

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Capital Goods

0.481

0.000

0.000

 

 

Raw Materials

1522.396

1299.467

1168.685

 

 

Consumables

0.028

0.156

0.321

 

TOTAL IMPORTS

1522.905

1299.623

1169.006

 

 

 

 

 

 

Earnings Per Share (Rs.)

26.12

19.33

17.61

 

Particulars

 

 

31.03.2014

31.03.2013

Sales Turnover (Approximately)

 

6000.000

6000.000

 

The above information has been parted by Ms. Swati.

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

7.03

7.09
6.38

 

 

 

 
 

Net Profit Margin

(PBT/Sales)

(%)

9.81

9.31
8.56

 

 

 

 
 

Return on Total Assets

(PBT/Total Assets}

(%)

8.58

8.28
7.00

 

 

 

 
 

Return on Investment (ROI)

(PBT/Networth)

 

0.32

0.29
0.30

 

 

 

 
 

Debt Equity Ratio

(Total Debt/Networth)

 

1.46

1.63
2.05

 

 

 

 
 

Current Ratio

(Current Asset/Current Liability)

 

1.33

1.53
2.47

 

 

 

FINANCIAL ANALYSIS

[All figures are in Rupees Millions]

 

Particular

 

31.03.2011

31.03.2012

 

 

(Rs. In Millions)

(Rs. In Millions)

Share Capital

 

159.332

160.489

Reserves & Surplus

 

1187.591

1597.865

Share Application money pending allotment

 

0.000

57.704

Net worth

 

1346.923

1816.058

 

 

 

 

long-term borrowings

 

1175.607

1066.429

Short term borrowings

 

1024.364

1577.492

Total borrowings

 

2199.971

2643.921

Debt/Equity ratio

 

1.633

1.456

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2010

31.03.2011

31.03.2012

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

3218.025

4171.774

5891.861

 

 

29.638

41.232

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2010

31.03.2011

31.03.2012

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

3218.025

4171.774

5891.861

Profit

208.370

296.726

416.183

 

6.48%

7.11%

7.06%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

Yes

18]

Major customers

Yes

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

Yes

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

 

LITIGATION DETAILS

 

HIGH COURT OF BOMBAY

 

CASE DETAILS

BENCH: BOMBAY

Presentation Date: 02/07/2013

Lodging No: WPST/17966/2013  Filing Date: 02/07/2013   Reg. No.: WP/5870/2013   Reg. Date: 05/07/2013

Petitioner: MAHARASHTRA STATE ELECTRICITY DISTRIC     Respondent: CALYX CHEMICALS AND

                                                                                                  PHARMACEUTICALS LIMITED

Petn. Adv : DSK LEGAL (0)                                                       

District: THANE                                                                              Resp. Adv.:- PRAVIN D. KADAM (348)

Bench: SINGLE

Status: Pre-Admission                                                                 

Next Date: 30/07/2014                                                                  Stage: PETITIONS FOR ADMISSION AFTER

                                                                                                                   NOTICE (CIVIL SIDE MATTERS)

Coram:- ACCORDING TO SITTING LIST

Last Date:- 18/06/2014                                                               Stage: PETITIONS FOR ADMISSION AFTER

                                                                                                                  NOTICE (CIVIL SIDE MATTERS)

Last Coram: HON’BLE SHRI JUSTICE R.M. SAVANT

Act:  Electricity Supplies Act, 1948

 

 

CHANGE OF ADDRESS

 

The registered office of the company has been shifted from Unit No.2, Marwah’s Complex, Marwah Estate, Saki Vihar Road, Andheri (East), Mumbai – 400 072, Maharashtra to the present address w.e.f. 03.09.2012.

 

UNSECURED LOANS

 

 

31.03.2012

(Rs. in Millions)

31.03.2011

(Rs. in Millions)

LONG TERM BORROWINGS

 

 

Loans repayable on demand from others

12.819

12.819

Deferred payment liabilities

17.434

17.972

Deposits from others

0.150

0.100

Loans and advances from related parties

19.700

122.019

SHORT TERM BORROWINGS

 

 

Working capital loans from banks

0.000

100.000

Total

50.103

252.91

 

CORPORATE INFORMATION

 

Subject is a closely held public limited company domiciled in India and incorporated under the provisions of the Companies Act, 1956. The Company is engaged in manufacturing and dealing in Active Pharmaceutical Ingredients (APIs), Intermediates and Contract research and manufacturing services. The company caters to both domestic and international markets.

 


INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10489968

31/03/2014

500,000,000.00

THE JAMMU AND KASHMIR BANK LIMITED

MAHAKALI CAVES,, SUBHASH NAGAR, ANDHERI (EAST), MUMBAI - 400093, MAHARASHTRA, INDIA

C03753779

2

10406186

18/02/2013

200,000,000.00

UCO BANK

MCU ANDHERI (WEST), MAROL MAROSHI ROAD, NEXT TO M 
AROL FIRE BRIGADE, ANDHERI (E), MUMBAI - 400059, MAHARASHTRA, INDIA

B68691112

3

10400489

17/01/2013

275,000,000.00

EXPORT-IMPORT BANK OF INDIA

CENTRE ONE BUILDING, FLOOR 21, WORLD TRADE CENTRE 
COMPLEX, CUFFE PARADE, MUMBAI - 400005, MAHARASHTRA, INDIA

B66677725

4

10389644

04/12/2012

400,000,000.00

CORPORATION BANK

LARGE CORPORATE BRANCH, EAGLES FLIGHT,, SUREN ROA 
D, ANDHERI (E), MUMBAI - 400093, MAHARASHTRA, INDIA

B63207336

5

10379031

05/10/2012

600,000,000.00

STATE BANK OF TRAVANCORE

N.M.WADIA BUILDING, 125 M.G ROAD, MUMBAI - 400021, MAHARASHTRA, INDIA

B59100479

6

10365476

10/07/2012

52,200,000.00

DENA BANK

SHARE BAZAR BRANCH, HAMAM STREET, MUMBAI - 400023, MAHARASHTRA, INDIA

B43627074

7

10367854

04/07/2012

100,000,000.00

BANK OF MAHARASHTRA

SHASHTRI HALL,, 292 , TARDEO ROAD,, MUMBAI - 400007, MAHARASHTRA, INDIA

B44626364

8

10368035

04/07/2012

150,000,000.00

BANK OF MAHARASHTRA

SHASHTRI HALL,, 292 , TARDEO ROAD,, MUMBAI - 400007, MAHARASHTRA, INDIA

B44696557

9

10365935

23/06/2012

400,000,000.00

STATE BANK OF BIKANER AND JAIPUR

COMMERCIAL NETWORK BRANCH, 239,, P.D'MELLO ROAD, 
NEAR G.P.O., MUMBAI - 400001, MAHARASHTRA, INDIA

B43778810

10

10364958

17/10/2012 *

6,459,000,000.00

SBICAP TRUSTEE COMPANY LIMITED

202, MAKER TOWER, 'E', CUFFE PARADE,, COLABA,, MUMBAI - 400005, MAHARASHTRA, INDIA

B60027612

11

10360984

23/05/2012

200,000,000.00

STATE BANK OF BIKANER AND JAIPUR

COMMERCIAL NETWORK BRANCH,, 239,P.D'MELLO ROAD, NEAR G.P.O, MUMBAI - 400001, MAHARASHTRA, INDIA

B41781865

12

10323423

15/12/2011

50,000,000.00

EXPORT-IMPORT BANK OF INDIA

CENTRE ONE BUILDING, FLOOR 21, WORLD TRADE CENTRE 
COMPLEX, CUFFE PARADE, MUMBAI - 400005, MAHARASHTRA, INDIA

B27972421

13

10323416

15/12/2011

250,000,000.00

EXPORT-IMPORT BANK OF INDIA

CENTRE ONE BUILDING, FLOOR 21, WORLD TRADE CENTRE 
COMPLEX, CUFFE PARADE, MUMBAI - 400005, MAHARASHTRA, INDIA

B27971837

14

10293104

18/05/2011

270,000,000.00

SBI GLOBAL FACTORS LIMITED

6TH FLOOR, METROPOLITAN BUILDING, BANDRA-KURLA, C 
OMPLEX, BANDRA(EAST), MUMBAI - 400051, MAHARASHTRA, INDIA

B15321300

15

10238777

22/02/2012 *

4,768,000,000.00

STATE BANK OF INDIA

BACKBAY RECLAMATION BRANCH,RAHEJA CHAMBERS,, NARI 
MAN POINT, MUMBAI - 400021, MAHARASHTRA, INDIA

B36744563

16

90219177

17/03/2004

30,000,000.00

STATE BANK OF INDIA

BACKBAY RECLAMATION, MUMBAI - 400021, MAHARASHTRA, INDIA

-

17

80058733

25/06/2004 *

44,000,000.00

SBI FACTOR AND COMMERCIAL SERVICES LTD.

BANDRA (W), MUMBAI - 400050, MAHARASHTRA, INDIA

-

18

90218409

06/10/2009 *

2,585,000,000.00

STATE BANK OF INDIA

BACKBAY RECLAMATION BRANCH,RAHEJA CHAMBERS,, NARI 
MAN POINT, MUMBAI - 400021, MAHARASHTRA, INDIA

A72624505

 

FIXED ASSETS

 

·         Leasehold Land

·         Building

·         Plant and Machinery

·         Air Conditioner

·         Computer

·         Electrical Installation

·         Furniture and Fixture

·         Laboratory Equipment

·         Vehicles

·         Office Equipment

·         Air Conditioner

·         Computer

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgment or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration:

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration:

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime:

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws:

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards:

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government:

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package:

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report:

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.87

UK Pound

1

Rs.99.63

Euro

1

Rs.78.22

 

 

INFORMATION DETAILS

 

Information Gathered by :

PRT

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

JAY

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

50

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.